Back to top

Bull of the Day

Encouraged by strong second quarter 2012 results, upbeat guidance and a series of positive subsequent developments, we are upgrading Bayer AG ADRs (BAYRY) to Outperform. Bayer performed impressively in the second quarter of 2012 driven by increased revenues. Management also raised guidance for 2012 revenues as well as earnings.

Subsequently, Bayer has witnessed a series of positive developments, including progress regarding oncology candidate regorafenib and label expansion efforts for Xarelto. Moreover, the decision of Bayer's HealthCare unit to buy Teva's animal health business in the US is also a positive move.

Consequently, we believe that the current price represents an attractive entry point for long-term investors. Over the last five years, Bayer has traded in a range of 9.1x to 28.3x trailing 12-month earnings. Our target price of $103.00 is based on approximately 15.1x our 2012 EPADS estimate of $6.81.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
PLANAR SYST… PLNR 4.44 +5.21%
BITAUTO HOL… BITA 81.71 +5.12%
CTPARTNERS… CTP 16.66 +4.26%
CHINA BIOLO… CBPO 47.91 +3.30%
MALLINCKROD… MNK 72.94 +2.85%